Greater dissolution and penetration into ocular tissue than the micronized gel 0.5% formulation because of the submicron drug particle size (median ranges between 0.4 and 0.6 µm).

Lower drug concentration per dose and less frequent administration than the micronized 0.5% gel.

Reduces post-operative inflammation and pain following cataract surgery.

Generally well tolerated with minimal impact on IOP.